To investigate the ligand-binding site of the human endothelin-A-receptor subtype (ETA), we have produced various chimeric and mutated receptors in Chinese hamster ovary cells. The substitution of Lysl40 with Ile located in the C-terminus of the second transmembrane region caused a 13-fold reduction in affinity for endothelin-1 (ET-1) and 3.6-fold lower B,,, than those values for the original receptor. Correspondingly, the mutated ETA receptor with the Lysl40-Ile substitution failed to induce an increase in the intracellular calcium concentration in the presence of 1 nM ET-1. Thus, the Lysl40 in the ETA receptor is important in ligand binding. ETA and ET, receptors possess the ET isopeptides selective and non-selective binding activities, respectively. Displacement experiments and the binding of '251-ET-3 to various chimera receptors demonstrated that both the third and fourth extracellular regions, including the flanking transmenbrane regions, are responsible for the ligand-binding selectivity of the ETA receptor.Endothelin-1 (ET-1) is a novel potent vasoconstrictor peptide with 21 amino acid residues, originally characterized from the supernatant of cultured porcine endothelial cells [I]. Analysis of human genomic DNA [2j revealed the existence of three distinct genes encoding three ET isopeptides (ET-1, ET-2 and ET-3). ET-2 has a close resemblance to with Leu6 and Met7 substituted for Trp6 and Leu7, respectively, whereas ET-3 is different from both ET-1 and ET-2 at six positions located in the inner loop common to all three ET peptides [2]. These peptides show a wide range of biological activities such as receptor binding, contraction, phosphatidylinositol turnover, neurotransmitter, increase in intracellular calcium concentration, stimulation of DNA synthesis, secretion of aldosterone, atrial natriuretic peptide and gonadotropin, and increase in blood pressure [2-91.We have previously reported cloning of the two human proximity to the first transmembrane region is required for the ligand-binding activity of the ETA receptor [14]. The overall structure of the ET receptor shows significant sequence and topographical similarities with the photoreceptor rhodopsin and other guanine-nucleotide-binding-regulatory protein(G-protein)-coupled receptors. Both the cloned human ETA and ET, cDNAs have been expressed in transfected COS cells [I 0, 11 j. As expected, the expressed ETA receptor represented different affinities to the three endothelin isoforms in the order of ET-l>ET-2@ET-3 [lo], while the ET, receptor binds to ET-1, ET-2 and ET-3 with an almost equal affinity [ll]. The different pharmacological activities of the ET isopeptides seem to be ascribed to different localization of ETA and ET, receptors and different signal-transduction pathways. Indeed, the ETA receptor predominantly exists in vascular smooth-muscle cells and plays a major role in vasoconstriction [2, 151. The ET, receptor, which is predominantly present in vascular endothelium cells and abundant in the brain and lung [16, 171, mediates not on...